1. Introduction
1.1. Market Definition
1.2. Market Segmentation
2. Research Methodology
2.1. Research Data
2.2. Assumptions
3. Executive Summary
3.1. Research Highlights
4. Market Dynamics
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. The threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. Global Aptamers Market Analysis, By Type
5.1. Introduction
5.2. DNA based Aptamers
5.3. RNA based Aptamers
5.4. Peptide based Aptamers
6. Global Aptamers Market Analysis, By Application
6.1. Introduction
6.2. Therapeutic
6.3. Diagnostics
6.4. Others
7. Global Aptamers Market Analysis, By End-User
7.1. Introduction
7.2. Research Institutes
7.3. Biotechnology Companies
7.4. Pharmaceutical Companies
8. Global Aptamers Market Analysis, By Geography
8.1. Introduction
8.2. North America
8.2.1. United States
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. UK
8.4.2. France
8.4.3. Germany
8.4.4. Italy
8.4.5. Others
8.5. The Middle East and Africa
8.6. Asia Pacific
8.6.1. Japan
8.6.2. China
8.6.3. India
8.6.4. Thailand
8.6.5. Taiwan
8.6.6. Indonesia
8.6.7. Others
9. Competitive Environment and Analysis
9.1. Major Players and Strategy Analysis
9.2. Emerging Players and Market Lucrativeness
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Vendor Competitiveness Matrix
10. Company Profiles
10.1. Aptamer Sciences
10.2. Raptamer Discovery Group
10.3. Aptagen LLC
10.4. Veraptus
10.5. AMS Biotechnology Limited
10.6. Aptamer Group
10.7. Novaptech
10.8. Elixin Pharma
10.9. Base Pair Technologies
10.10. Aptus BiotechList of FiguresList of Tables